S. Kalay Et Al. , "Beneficial effect of triple treatment (ACEI, AT1RB, statin) plus immunoglobulin in experimental nephrotic syndrome," 59th Annual Meeting of the American-Association-for-Clinical-Chemistry , vol.53, California, United States Of America, 2007
Kalay, S. Et Al. 2007. Beneficial effect of triple treatment (ACEI, AT1RB, statin) plus immunoglobulin in experimental nephrotic syndrome. 59th Annual Meeting of the American-Association-for-Clinical-Chemistry , (California, United States Of America).
Kalay, S., AKMAN, S., Akkaya, B., Koyun, M., AKBAŞ, S. H., Baysal, Y., ... Guven, A. G.(2007). Beneficial effect of triple treatment (ACEI, AT1RB, statin) plus immunoglobulin in experimental nephrotic syndrome . 59th Annual Meeting of the American-Association-for-Clinical-Chemistry, California, United States Of America
Kalay, S. Et Al. "Beneficial effect of triple treatment (ACEI, AT1RB, statin) plus immunoglobulin in experimental nephrotic syndrome," 59th Annual Meeting of the American-Association-for-Clinical-Chemistry, California, United States Of America, 2007
Kalay, S. Et Al. "Beneficial effect of triple treatment (ACEI, AT1RB, statin) plus immunoglobulin in experimental nephrotic syndrome." 59th Annual Meeting of the American-Association-for-Clinical-Chemistry , California, United States Of America, 2007
Kalay, S. Et Al. (2007) . "Beneficial effect of triple treatment (ACEI, AT1RB, statin) plus immunoglobulin in experimental nephrotic syndrome." 59th Annual Meeting of the American-Association-for-Clinical-Chemistry , California, United States Of America.
@conferencepaper{conferencepaper, author={S. Kalay Et Al. }, title={Beneficial effect of triple treatment (ACEI, AT1RB, statin) plus immunoglobulin in experimental nephrotic syndrome}, congress name={59th Annual Meeting of the American-Association-for-Clinical-Chemistry}, city={California}, country={United States Of America}, year={2007}}